{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:09:33Z","timestamp":1649030973854},"reference-count":15,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-14-0673","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T23:07:24Z","timestamp":1404774444000},"page":"1828-1829","source":"Crossref","is-referenced-by-count":0,"title":["Role of Telomere Length in Interindividual Variation in Cardiovascular Protection in Hypertensive Patients"],"prefix":"10.1253","volume":"78","author":[{"given":"Satoshi","family":"Hoshide","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Department of Sleep and Circadian Cardiology, Jichi Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. NguyenHN,FujiyoshiA,AbbottRD,MiuraK.Epidemiology of cardiovascular risk factors in asian countries.<i>Circ J<\/i>2013;77:2851\u20132859.","DOI":"10.1253\/circj.CJ-13-1292"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. HarleyCB,FutcherAB,GreiderCW.Telomeres shorten during ageing of human fibroblasts.<i>Nature<\/i>1990;345:458\u2013460.","DOI":"10.1038\/345458a0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. SamaniNJ,BoultbyR,ButlerR,ThompsonJR,GoodallAH.Telomere shortening in atherosclerosis.<i>Lancet<\/i>2001;358:472\u2013473.","DOI":"10.1016\/S0140-6736(01)05633-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van der HarstP,van der SteegeG,de BoerRA,VoorsAA,HallAS,MulderMJ, et al.Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.<i>J Am Coll Cardiol<\/i>2007;49:1459\u20131464.","DOI":"10.1016\/j.jacc.2007.01.027"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. CawthonRM,SmithKR,O\u2019BrienE,SivatchenkoA,KerberRA.Association between telomere length in blood and mortality in people aged 60 years or older.<i>Lancet<\/i>2003;361:393\u2013395.","DOI":"10.1016\/S0140-6736(03)12384-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. ZhangDH,WenXM,ZhangL,CuiW.DNA methylation of human telomerase reverse transcriptase associated with leukocyte telomere length shortening in hyperhomocysteinemia-type hypertension in humans and in a rat model.<i>Circ J<\/i>2014;78:1915\u20131923.","DOI":"10.1253\/circj.CJ-14-0233"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. EikelboomJW,LonnE,GenestJJr,HankeyG,YusufS.Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence.<i>Ann Intern Med<\/i>1999;131:363\u2013375.","DOI":"10.7326\/0003-4819-131-5-199909070-00008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. WaldDS,LawM,MorrisJK.Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis.<i>BMJ<\/i>2002;325:1202.","DOI":"10.1136\/bmj.325.7374.1202"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Banos-GonzalezMA,Angles-CanoE,Cardoso-SaldanaG,Pena-DuqueMA,Martinez-RiosMA,Valente-AcostaB, et al.Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects.<i>Circ J<\/i>2012;76:1953\u20131957.","DOI":"10.1253\/circj.CJ-12-0039"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. WelchGN,LoscalzoJ.Homocysteine and atherothrombosis.<i>N Engl J Med<\/i>1998;338:1042\u20131050.","DOI":"10.1056\/NEJM199804093381507"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. von ZglinickiT.Role of oxidative stress in telomere length regulation and replicative senescence.<i>Ann NY Acad Sci<\/i>2000;908:99\u2013110.","DOI":"10.1111\/j.1749-6632.2000.tb06639.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. TowfighiA,ArshiB,MarkovicD,OvbiageleB.Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: The impact of age in the VISP trial.<i>Cerebrovasc Dis<\/i>2014;37:263\u2013267.","DOI":"10.1159\/000360153"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. ParatiG,OchoaJE,LombardiC,BiloG.Assessment and management of blood-pressure variability.<i>Nature Rev Cardiol<\/i>2013;10:143\u2013155.","DOI":"10.1038\/nrcardio.2013.1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. HoshideS,YanoY,ShimizuM,EguchiK,IshikawaJ,KarioK.Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment?<i>Hypertens Res<\/i>2012;35:862\u2013866.","DOI":"10.1038\/hr.2012.46"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014).<i>HypertensRes<\/i>2014;37:253.","DOI":"10.1038\/hr.2014.20"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/8\/78_CJ-14-0673\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T04:15:17Z","timestamp":1616645717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/8\/78_CJ-14-0673\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-0673","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}